Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Jersey Health Reporter.
Press releases published on June 9, 2025
The Recovery Team - New Jersey Opens New Facility to Expand Access to Addiction Treatment
EIN Presswire
·
June 9, 2025
New Mountainside facility offers substance use treatment, including partial hospitalization and outpatient services in the tri-state area. UNION, NJ, UNITED STATES, June 9, 2025 /EINPresswire.com/ -- The Recovery Team - New Jersey opens its doors today, …
Comfort Keepers Expands Partnerships with Local Healthcare Providers to Improve Continuity of Senior Care
EIN Presswire
·
June 9, 2025
PITMAN, NJ, UNITED STATES, June 9, 2025 /EINPresswire.com/ -- Comfort Keepers of Southern New Jersey is pleased to announce an expanded collaboration with local healthcare providers across the region to enhance the continuity of care for seniors …
Comfort Keepers of Central New Jersey and Elder Law Attorneys Team Up to Support Holistic Aging Plans
EIN Presswire
·
June 9, 2025
SHREWSBURY, NJ, UNITED STATES, June 9, 2025 /EINPresswire.com/ -- Comfort Keepers of Central New Jersey is proud to announce a new partnership with trusted elder law attorneys across the region to better support seniors and their families with …
SOBA New Jersey Offers Telehealth Therapy Options for Remote & Convenient Addiction and Mental Health Care
EIN Presswire
·
June 9, 2025
Balancing busy schedules can make it challenging for many individuals, such as parents, full-time workers, and students, to attend in-person treatment. NEW BRUNSWICK, NJ, UNITED STATES, June 9, 2025 /EINPresswire.com/ -- Balancing busy schedules can …
Thirteen Studies of Ascentage Pharma’s Assets Including Olverembatinib and Lisaftoclax Selected for Presentations at 2025 European Hematology Association Annual Congress
GlobeNewswire
·
June 9, 2025
ROCKVILLE, Md. and SUZHOU, China, June 09, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced that 13 studies of its core assets - …
AriBio and Arcera Sign Exclusive Licensing and Supply Agreements for Investigational Drug for Alzheimer’s Disease
GlobeNewswire
·
June 9, 2025
Seongnam-si, South Korea and Abu Dhabi, UAE, June 09, 2025 (GLOBE NEWSWIRE) -- AriBio Co., Ltd. ("AriBio"), a South Korean biopharmaceutical company specializing in neurodegenerative diseases, and a Swiss pharmaceutical company Acino, part of Arcera, a …
Senti Biosciences Announces New Employment Inducement Grants
GlobeNewswire
·
June 9, 2025
SOUTH SAN FRANCISCO, Calif., June 09, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, …
Aspen Ideas: Health 2025 Launches Agenda Spotlighting Bold Innovations and Urgent Challenges in Health
GlobeNewswire
·
June 9, 2025
Aspen, CO, June 09, 2025 (GLOBE NEWSWIRE) -- Today, Aspen Ideas: Health, the Aspen Institute's annual premiere health gathering, launched its agenda and full speaker lineup. From June 22-25, policymakers, healthcare providers, public health practitioners, …
MannKind to Highlight Data from Recent Pediatric and Adult Studies of Inhaled Insulin (Afrezza®) at American Diabetes Association’s 85th Scientific Sessions in Chicago, June 20-23
GlobeNewswire
·
June 9, 2025
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., June 09, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products and delivery devices for patients with endocrine …
Registration Is Now Open For Tribe Public’s CEO Presentation and Q&A Webinar Event "Is the Beaten Down Biotech Sector the Smartest Bet in Today's Volatile Market?"
GlobeNewswire
·
June 9, 2025
Featuring Serina Therapeutics’ CEO - Wednesday, June 11, 2025 Entering year 5 of a biotech bear market, approximately 25% of the 700 – 800 publicly traded US biotech companies have negative enterprise values Recognize the patterns that can lead to strong …
Roivant and Priovant to Host Investor Video Conference at 1:00 PM ET on Tuesday, June 17 on Brepocitinib and the Unmet Medical Need in Dermatomyositis
GlobeNewswire
·
June 9, 2025
BASEL, Switzerland and LONDON and NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) and Priovant Therapeutics today announced that they will host a live investor video conference at 1:00 PM ET on Tuesday, June 17 on brepocitinib, the unmet …
Venus Concept Announces Closing of Up To $3.45 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
GlobeNewswire
·
June 9, 2025
TORONTO, June 09, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced the closing of its previously announced registered direct offering priced at-the- …
Sana Biotechnology Announces Invited Oral Presentation at the 85th Annual American Diabetes Association Scientific Sessions
GlobeNewswire
·
June 9, 2025
SEATTLE, June 09, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced an upcoming podium presentation highlighting ongoing clinical data from …
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
June 9, 2025
BRISBANE, Calif., June 09, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on June 3, 2025, the Compensation Committee granted inducement awards consisting of non-qualified stock options to purchase 124,000 shares of …
Lyell Immunopharma Strengthens Clinical and Commercial Capabilities with Key Board and Executive Appointments
GlobeNewswire
·
June 9, 2025
Mark J. Bachleda, PharmD, MBA appointed as independent member of the Board of Directors David Shook, MD appointed as Chief Medical Officer, Mark Meltz, JD as General Counsel and Corporate Secretary, and Jarrad Aguirre, MD, MBA as Senior Vice-President of …
FibroGen Appoints Michael Kauffman, M.D., Ph.D. to its Board of Directors
GlobeNewswire
·
June 9, 2025
SAN FRANCISCO, June 09, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced the appointment of Dr. Michael Kauffman to its Board of Directors effective June 4, 2025. “Michael is a well-recognized biotech industry veteran, who brings a …
MUSE Microscopy, Inc. Launches Veterinary Digital Pathology with the First-of-Its-Kind Tissue-to-Direct Digital Imaging for the Veterinary Market
GlobeNewswire
·
June 9, 2025
IRVINE, Calif., June 09, 2025 (GLOBE NEWSWIRE) -- MUSE Microscopy, Inc., a pioneer in digital pathology innovation, today announced the formation of MUSE Veterinary Digital Pathology, LLC, a wholly-owned subsidiary focused on transforming pathology through …
Sharps Technology CEO, Robert Hayes, to Present at the Virtual Investor Summit on June 10, 2025
GlobeNewswire
·
June 9, 2025
NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (Nasdaq: “STSS” and “STSSW”) (“Sharps”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class smart safety syringe products to the healthcare …
BioSig & Streamex Appoint Parcl Co-Founders Trevor Bacon and Kellan Grenier as Strategic Advisors
GlobeNewswire
·
June 9, 2025
Los Angeles, CA …
Over 100 Organizations Launch Blood Advocacy Week 2025 Urging Congress to Make the Blood Supply a National Priority
GlobeNewswire
·
June 9, 2025
Washington, DC, June 09, 2025 (GLOBE NEWSWIRE) -- Over 100 leading organizations from across the nation have united to kick off Blood Advocacy Week 2025, calling on Members of Congress to take decisive action in supporting the blood supply as a national …